Dermatoscopic patterns of cutaneous metastases: A multicentre cross-sectional study of the International Dermoscopy Society.


Journal

Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037

Informations de publication

Date de publication:
14 Mar 2024
Historique:
received: 08 12 2023
accepted: 14 02 2024
medline: 14 3 2024
pubmed: 14 3 2024
entrez: 14 3 2024
Statut: aheadofprint

Résumé

The detection of cutaneous metastases (CMs) from various primary tumours represents a diagnostic challenge. Our aim was to evaluate the general characteristics and dermatoscopic features of CMs from different primary tumours. Retrospective, multicentre, descriptive, cross-sectional study of biopsy-proven CMs. We included 583 patients (247 females, median age: 64 years, 25%-75% percentiles: 54-74 years) with 632 CMs, of which 52.2% (n = 330) were local, and 26.7% (n = 169) were distant. The most common primary tumours were melanomas (n = 474) and breast cancer (n = 59). Most non-melanoma CMs were non-pigmented (n = 151, 95.6%). Of 169 distant metastases, 54 (32.0%) appeared on the head and neck region. On dermatoscopy, pigmented melanoma metastases were frequently structureless blue (63.6%, n = 201), while amelanotic metastases were typified by linear serpentine vessels and a white structureless pattern. No significant difference was found between amelanotic melanoma metastases and CMs of other primary tumours. The head and neck area is a common site for distant CMs. Our study confirms that most pigmented melanoma metastasis are structureless blue on dermatoscopy and may mimic blue nevi. Amelanotic metastases are typified by linear serpentine vessels and a white structureless pattern, regardless of the primary tumour.

Sections du résumé

BACKGROUND BACKGROUND
The detection of cutaneous metastases (CMs) from various primary tumours represents a diagnostic challenge.
OBJECTIVES OBJECTIVE
Our aim was to evaluate the general characteristics and dermatoscopic features of CMs from different primary tumours.
METHODS METHODS
Retrospective, multicentre, descriptive, cross-sectional study of biopsy-proven CMs.
RESULTS RESULTS
We included 583 patients (247 females, median age: 64 years, 25%-75% percentiles: 54-74 years) with 632 CMs, of which 52.2% (n = 330) were local, and 26.7% (n = 169) were distant. The most common primary tumours were melanomas (n = 474) and breast cancer (n = 59). Most non-melanoma CMs were non-pigmented (n = 151, 95.6%). Of 169 distant metastases, 54 (32.0%) appeared on the head and neck region. On dermatoscopy, pigmented melanoma metastases were frequently structureless blue (63.6%, n = 201), while amelanotic metastases were typified by linear serpentine vessels and a white structureless pattern. No significant difference was found between amelanotic melanoma metastases and CMs of other primary tumours.
CONCLUSIONS CONCLUSIONS
The head and neck area is a common site for distant CMs. Our study confirms that most pigmented melanoma metastasis are structureless blue on dermatoscopy and may mimic blue nevi. Amelanotic metastases are typified by linear serpentine vessels and a white structureless pattern, regardless of the primary tumour.

Identifiants

pubmed: 38483241
doi: 10.1111/jdv.19962
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Scott W Menzies (SW)
Sakitha Maljini (S)
H Peter Soyer (HP)
Alessandro Di Stefani (A)
Teresa Maria Kränke (TM)
Paweł Pietkiewicz (P)
Martyna Sławińska (M)
Michał Sobjanek (M)
Zsuzsanna Lengyel (Z)
Verche Todorovska (V)
Zeljko Mijuskovic (Z)
Tatjana Radevic (T)
Sladjana Cekic (S)
Savoia Francesco (S)
María Belén Marín (MB)
Rosario Peralta (R)
Danijela Popovic (D)
Konstantinos Liopyris (K)
Giulia Briatico (G)

Informations de copyright

© 2024 European Academy of Dermatology and Venereology.

Références

Lookingbill DP, Spangler N, Sexton FM. Skin involvement as the presenting sign of internal carcinoma: a retrospective study of 7316 cancer patients. J Am Acad Dermatol. 1990;22(1):19-26.
Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol. 1993;29(2):228-236.
Spencer PS, Helm TN. Skin metastases in cancer patients. Cutis. 1987;39(2):119-121.
Schwartz RA. Cutaneous metastatic disease. J Am Acad Dermatol. 1995;33:161-182.
Krathen RA, Orengo IF, Rosen T. Cutaneous metastasis: a meta-analysis of data. South Med J. 2003;96(2):164-167.
Rosen T. Cutaneous metastases. Med Clin North Am. 1980;64:885-900.
Nashan D, Müller ML, Braun-Falco M, Reichenberger S, Szeimies RM, Bruckner-Tuderman L. Cutaneous metastases of visceral tumours: a review. J Cancer Res Clin Oncol. 2009;135:1-14.
Bono R, Giampetruzzi AR, Concolino F, Puddu P, Scoppola A, Sera F, et al. Dermoscopic patterns of cutaneous melanoma metastases. Melanoma Res. 2004;14(5):367-373.
Jaimes N, Halpern JA, Puig S, Malvehy J, Myskowski PL, Braun RP, et al. Dermoscopy: an aid to the detection of amelanotic cutaneous melanoma metastases. Dermatol Surg. 2012;38(9):1437-1444.
Costa J, Ortiz-Ibañez K, Salerni G, Borges V, Carrera C, Puig S, et al. Dermoscopic patterns of melanoma metastases: interobserver consistency and accuracy for metastasis recognition. Br J Dermatol. 2013;169(1):91-99.
Chernoff KA, Marghoob AA, Lacouture ME, Deng L, Busam KJ, Myskowski PL. Dermoscopic findings in cutaneous metastases. JAMA Dermatol. 2014;150(4):429-433.
Kostaki M, Plaka M, Moustaki M, Befon A, Champsas G, Kypreou K, et al. Cutaneous melanoma metastases: clinical and dermoscopic findings. J Eur Acad Dermatol Venereol. 2023;37:941-944.
Plaza JA, Torres-Cabala C, Evans H, Diwan HA, Suster S, Prieto VG. Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum. Am J Dermatopathol. 2010;32(2):129-136.
Savoia P, Fava P, Nardò T, Osella-Abate S, Quaglino P, Bernengo MG. Skin metastases of malignant melanoma: a clinical and prognostic survey. Melanoma Res. 2009;19:321-326.
Keung EZ, Gershenwald JE. The eighth edition American joint committee on cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert Rev Anticancer Ther. 2018;18(8):775-784.
Vernemmen AIP, Li X, Roemen GMJM, Speel EM, Kubat B, Hausen AZ, et al. Cutaneous metastases of internal malignancies: a single-institution experience. Histopathology. 2022;81(3):329-341.

Auteurs

Danica Tiodorovic (D)

Clinic of Dermatovenerology, University Clinical Center of Nis, Medical Faculty, University of Nis, Nis, Serbia.

Jelena Stojkovic-Filipovic (J)

Clinic of Dermatology and Venereology, University Clinical Center of Serbia, Faculty of Medicine, Department of Dermatology and Venereology, University of Belgrade, Belgrade, Serbia.

Ashfaq Marghoob (A)

Memorial Sloan Kettering Cancer Center, Uniondale, New York, USA.

Giuseppe Argenziano (G)

Dermatology Unit, University of Campania, Naples, Italy.

Susana Puig (S)

Dermatology Department, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.

Josep Malvehy (J)

Dermatology Department, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.

Linda Tognetti (L)

Dermatology Unit, Department of Medical, Surgical and Neurosciences, University of Siena, Siena, Italy.

Rubegni Pietro (R)

Dermatology Unit, Department of Medical, Surgical and Neurosciences, University of Siena, Siena, Italy.

Bengu Nisa Akay (BN)

Medicine Faculty Department of Dermatology, Ankara University, Ankara, Turkey.

Iris Zalaudek (I)

Department of Dermatology and Venerology, Medical University of Trieste, Trieste, Italy.

Holger A Haenssle (HA)

Department of Dermatology, University of Heidelberg, Heidelberg, Germany.

Christine Müller-Christmann (C)

Department of Dermatology, University of Heidelberg, Heidelberg, Germany.

Elisa Cinotti (E)

Dermatology Unit, Department of Medical, Surgical and Neurosciences, University of Siena, Siena, Italy.

Jean Luc Perrot (JL)

Department of Dermatology, CHU Saint Etienne, Saint-Etienne, France.

Pedro Zaballos (P)

Dermatology Department, Hospital de Sant Pau i Santa Tecla, Tarragota, Spain.

Renato Marchiori Bakos (RM)

Department of Dermatology, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul-Porto Alegre, Porto Alegre, Brazil.

Luc Thomas (L)

Department of Dermatology, Centre Hospitalier Lyon Sud, Lyons Cancer Research Center, Lyon 1 University, Lyon, France.

Ketty Peris (K)

Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Aimilios Lallas (A)

First Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University, Thessaloniki, Greece.

Zoe Apalla (Z)

First Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University, Thessaloniki, Greece.

Juergen F Kreusch (JF)

Private Dermatological Practice, Luebeck, Germany.

Isabelle Tromme (I)

Department of Dermatology and Melanoma Clinic St Luc Hospital, Catholic, University of Louvain, Brussels, Belgium.

Alexandros J Stratigos (AJ)

Andreas Sygros Hospital for Cutaneous and Venereal Diseases, Athens, Greece.

Maria Antonietta Pizzichetta (MA)

Department of Dermatology, University of Trieste, Aviano, Italy.
Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Lidija Kandolf (L)

Department of Dermatology and Venereology, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia.

Caterina Longo (C)

Department of Dermatology, University of Modena and Reggio Emili, Modena, Italy.
Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Skin Cancer Center, Reggio Emilia, Italy.

Andreas Blum (A)

Public, Private and Teaching Practice of Dermatology, Konstanz, Germany.

Masaru Tanaka (M)

Department of Dermatology, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan.

Rainer Hofmann-Wellenhof (R)

Department of Dermatology and Venerology, Medical University Graz, Graz, Austria.

Andrija Jovic (A)

Clinic of Dermatovenerology, University Clinical Center of Nis, Nis, Serbia.

John Paoli (J)

Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, Region Västra Götaland, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.

Marija Buljan (M)

Department of Dermatology and Venereology, Sestre Milosrdnice University Hospital Centre, School of Dental Medicine, University of Zagreb, Zagreb, Croatia.

Martina Espasandín-Arias (M)

Department of Dermatology, University Hospital of Pontevedra, Pontevedra, Spain.

Horacio Cabo (H)

University of Buenos Aires, Buenos Aires, Argentina.

Sonia Rodrigiez Saa (SR)

Department of Dermatology, Hospital Del Carmen, Mendoza, Argentina.

Gabriel Salerni (G)

Department of Dermatology, Hospital Provincial del Centenario, National University of Rosario, Rosario, Argentina.

Gianluca Nazzaro (G)

Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Grazyna Kaminska-Winciorek (G)

Department of Bone Marrow Transplantation and Hematology-Oncology; Skin Cancer and Melanoma Team, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland.

Giovanni Damiani (G)

Italian Center of Precisione Medicine and Chronic Inflammation Milan, Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.

Franciska Geszti (F)

Smartderm Medical Office, Budapest, Hungary.

Harald Kittler (H)

Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Classifications MeSH